KRAS and pancreatic neoplasm: In a mouse model of Kras mutant pancreatic cancer, LKB1 loss instead resulted in mTOR-dependent induction of the serine-glycine-one-carbon (SGOC) pathway coupled to S-adenosylmethionine (SAMe) generation [36].